Gilead Sciences to Acquire Arcellx in $7.8B Deal to Advance Anito-cel
Gilead Arcellx Acquisition Announced The Gilead Arcellx acquisition marks a major expansion of Gilead Sciences’ oncology and cell therapy portfolio. Gilead has entered into a definitive agreement to acquire...

